Parallel Advisors, LLC Inovio Pharmaceuticals, Inc. Transaction History

Parallel Advisors, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 20, 2024	BUY	$0.38 - $0.58 $486 - $742	1,280 New	1,280 $0
Q3 2023 Nov 13, 2023	BUY	$0.38 - $0.58 $486 - $742	1,280 New	1,280 $0
Q4 2021 Jan 20, 2022	SELL	$4.99 - $7.46 $973 - $1,454	-195 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$7.16 - $9.69 $214 - $290	30 Added 18.18%	195 $1,000
Q2 2021 Aug 06, 2021	SELL	$6.23 - $10.03 $691 - $1,113	-111 Reduced 40.22%	165 $2,000
Q1 2021 Apr 23, 2021	BUY	$8.81 - $16.96 $2,431 - $4,680	276 New	276 $3,000
Q4 2020 Feb 02, 2021	SELL	$8.5 - $12.85 $2,550 - $3,855	-300 Closed	0 $0
Q3 2020 Oct 27, 2020	BUY	$9.57 - $27.05 $2,421 - $6,843	253 Added 538.3%	300 $3,000
Q2 2020 Jul 16, 2020	SELL	$7.14 - $31.69 $556 - $2,471	-78 Reduced 62.4%	47 $1,000
Q1 2020 Apr 27, 2020	BUY	$2.98 - $14.09 $372 - $1,761	125 New	125 $0
Q1 2019 May 01, 2019	SELL	$3.34 - $5.1 $1,035 - $1,581	-310 Closed	0 $0
Q1 2018 May 08, 2018	BUY	$4.05 - $5.69 $1,255 - $1,763	310 New	310 $1,000
Q3 2017 Nov 14, 2017	SELL	$5.36 - $6.37 $1,608 - $1,911	-300 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	300	300 $2,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $499M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.